Posted on May 30, 2025 by ASCO Editorial Team
Artificial intelligence (AI) is reshaping the future of cancer research and care. At the ASCO 2025 Annual Meeting, three education sessions will dive into how AI is revolutionizing oncology, from clinical trials to patient care. This post explores these sessions, their key takeaways, and what they mean for the future of cancer treatment.
The Rise of AI in Cancer Research
AI in oncology is making waves by streamlining processes and enhancing patient outcomes. From planning clinical trials to supporting therapeutic decisions, AI is becoming a game-changer in cancer care. The ASCO 2025 sessions will highlight the latest advancements, challenges, and future directions of this technology.
Session 1: Accelerating Clinical Trials with AI
Date and Time: May 30, 2025, 8:00 AM
Chaired by Dr. Sandip Patel from UC San Diego Moores Cancer Center, this session explores how AI optimizes clinical trial planning and patient recruitment. Experts, including Mark Stewart, PhD, and Donna Rivera, MSc, PharmD, will discuss AI’s role in matching patients to trials, improving trial design, and increasing diversity in oncology studies.
“AI can streamline repetitive tasks in clinical trials, reducing patient burden and enhancing study efficiency,” says Dr. Patel.
Key topics include machine learning innovations and best practices for mitigating AI-related challenges in trial conduct.
Session 2: AI in the Clinic
Date and Time: May 31, 2025, 10:00 AM
Led by Dr. Katy French from The University of Texas MD Anderson Cancer Center, this session focuses on AI’s role in clinical settings. Experts Ming Tai-Seale, PhD, and Larry Edward Bilbrey Sr. will cover ambient listening technology, AI-generated patient responses, and scaling AI for community oncology clinics.
AI note-taking tools, for example, allow clinicians to focus on patients rather than documentation. However, challenges like ensuring patient consent and understanding of AI tools remain critical.
Session 3: AI-Assisted Cancer Care Delivery
Date and Time: May 30, 2025, 1:00 PM
Chaired by Dr. Debra Patt from Texas Oncology, this session delves into AI’s practical applications in therapeutic decision-making. Alongside Ravi Bharat Parikh, MD, MPP, Dr. Patt will explore how AI supports mammography scans, CT scan interpretation, and symptom control in clinical settings.
“It’s an incredible time where medicine won’t look the same in two years due to AI,” says Dr. Patt. She emphasizes that AI enhances care delivery without replacing clinicians.
The Future of AI in Oncology
AI is poised to transform every aspect of cancer care, from diagnostics to treatment. However, integrating AI requires addressing challenges like implementation management and patient trust. As Dr. Patt notes, “AI will be additive, allowing our workforce to be more efficient and effective.”
The ASCO 2025 sessions will provide a roadmap for leveraging AI in oncology, ensuring better outcomes for patients worldwide.
Related Links:
